Systematic / IUPAC Name: 1-(4-Fluorobenzyl)-N-{1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl}-1H-benzimidazol-2-amine
ID: Reference1890
Other Names:
Histaminos;
Paralergin;
Alermizol;
Astemison;
Laridal
; more
Formula: C28H31FN4O
Class: Therapeutics/Prescription Drugs
Astemizole mass spectral data can be found in a separate interface. The data are manually curated and of the highest quality.
Used Instruments | Q Exactive Plus Orbitrap |
No. of Spectral Trees | 1 |
No. of Spectra | 39 |
Tandem Spectra | MS1, MS2 |
Ionization Methods | ESI |
Analyzers | FT |
Last Modification | 1/16/2015 10:59:35 AM |
InChI | InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31) |
InChI Key | GXDALQBWZGODGZ-UHFFFAOYSA-N |
Canonical SMILES | COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F |
CAS | 68844779 |
Splash | |
Other Names |
Histaminos; Paralergin; Alermizol; Astemison; Laridal; Retolen; Astemizol; Histamen; Kelp; Hestazol; Metodih; Wareezol; Novo-mastizol A; Astemisan; Astemisol; Histazol; Metodik; Waruzol; Nono-nastizol A; 1-(p-Fluorobenzyl)-2-{[1-(p-methoxyphenethyl)-4-piperidyl]amino}benzimidazole; 1-(p-Fluorobenzyl)-2-({1-[2-(p-methoxyphenyl)ethyl]piperid-4-yl}amino)benzimidazole; 1-(4-Fluorobenzyl)-N-{1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}-1H-benzimidazol-2-amine; Benzimidazole, 1-(p-fluorobenzyl)-2-((1-(2-(p-methoxyphenyl)ethyl)piperid-4-yl)amino)-; 1-[(4-Fluorophenyl)methyl]-N-(1-{2-[4-(methyloxy)phenyl]ethyl}piperidin-4-yl)-1H-benzimidazol-2-amine; 1-[(4-Fluorophenyl)methyl]-N-{1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl}-1H-benzimidazol-2-amine; 1H-Benzimidazol-2-amine, 1-[(4-fluorophenyl)methyl]-N-{1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl}-; 1-(4-Fluorobenzyl)-N-[1-(4-methoxyphenethyl)piperidin-4-yl]-1H-benzo[d]imidazol-2-amine |
PubChem | 2247 |
Wikipedia | Astemizole |
ChemSpider | 2160 |
HMDb | HMDB14775 |
ChEMBL | CHEMBL296419 |
KEGG | C06832; D00234 |
ChemIDPlus | 068844779 |
ChEBI | CHEBI:2896 |
DrugBank | APRD00585 |